Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f52c68e4149a6c462b850d4e7cc2b2f9 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J31-006 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-567 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P5-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J31-00 |
filingDate |
2016-03-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5c704dd72318418d7899172649756b6d |
publicationDate |
2017-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-3214092-A1 |
titleOfInvention |
Prodrugs of the selective progesterone receptor modulator (sprm) (11.beta.,17.beta.)-17-hydroxy-11-[4-(methylsulphonyl)phenyl]-17-(pentafluoroethyl)estra-4,9-dien-3-one |
abstract |
This invention concerns Selective Progesterone Receptor Modulators (SPRM) in a prodrug form as well as to their application in therapy. (3α,11β,17β)-11-[4-(methylsulfonyl)phenyl]-17-(pentafluoroethyl)estra-4,9-diene-3,17-diol (Compound 1) is one of the invention prodrugs. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10485808-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3384913-A1 |
priorityDate |
2016-03-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |